Testing effectiveness (Phase 2)Study completedNCT00402649
What this trial is testing
Open-Label Study of H5 Vaccine in Participants of Protocol 04-077
Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 35